BSE filing, BSE: 524238. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Inject (Kerala) Ltd: key numbers
- Share price
- ₹11.19
- Market cap
- ₹163.9 Cr
- Revenue (annual)
- ₹36.32 Cr
- Net profit (annual)
- ₹1.81 Cr
- P/E (TTM)
- 54.8×Sector 46.5×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Inject (Kerala) Ltd
All →Gujarat Inject (Kerala) Board Meeting Date
Gujarat Inject Kerala Ltd scheduled a board meeting on 26 October 2026 to consider preferential allotment of shares and warrants. No amount was specified in the intimation.
Gujarat Inject (Kerala) Bags ₹6.25 Cr Order from Deon Energy Limited
Gujarat Inject Kerala received a Rs.6.25 Crore purchase order from Deon Energy for 8,065 solar panels (620 Wp). Delivery is due by October 2026.
- Value
- ₹6.25 Cr
- From
- Deon Energy Limited
- Execution
- October 2026
Gujarat Inject (Kerala) Bags ₹4.86 Cr Order from Zentaraa Infra Projects Private Limited
Gujarat Inject Kerala Ltd received a purchase order for 3,600 solar PV modules from Zentaraa Infra Projects Private Limited, valued at approximately ₹4.86 Crore.
- Value
- ₹4.86 Cr
- From
- Zentaraa Infra Projects Private Limited
- Execution
- October 2026
- Solar PV Modules
- 3600.0 units
Gujarat Inject (Kerala) Annual General Meeting
Gujarat Inject Kerala Ltd held its 35th AGM on September 29, 2026, to conduct routine business, including the adoption of financial statements and director appointments.
Gujarat Inject (Kerala) Stock Split
Gujarat Inject Kerala Ltd announced the completion of its 1:10 stock split. Shareholders holding physical certificates must now submit documentation to the RTA to receive dematerialized shares.
Gujarat Inject (Kerala) Management Change
Gujarat Inject Kerala Ltd has appointed M/s. S N D K & Associates LLP as the company's new Statutory Auditor. The appointment is effective from September 29, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.